These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31792870)

  • 41. Engagement in outpatient care for persons living with HIV in the United States.
    Oramasionwu C; Bailey SC; Johnson TL; Mao L
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):177-82. PubMed ID: 25386831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.
    Richard N; Juntilla M; Abraha A; Demers K; Paxinos E; Galovich J; Petropoulos C; Whalen CC; Kyeyune F; Atwine D; Kityo C; Mugyenyi P; Arts EJ
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):355-64. PubMed ID: 15157354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unanticipated Effects of New Drug Availability on Antiretroviral Durability: Implications for Comparative Effectiveness Research.
    Eaton EF; Tamhane AR; Burkholder GA; Willig JH; Saag MS; Mugavero MJ
    Open Forum Infect Dis; 2016 Apr; 3(2):ofw109. PubMed ID: 27419181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.
    Ávila-Ríos S; García-Morales C; Matías-Florentino M; Romero-Mora KA; Tapia-Trejo D; Quiroz-Morales VS; Reyes-Gopar H; Ji H; Sandstrom P; Casillas-Rodríguez J; Sierra-Madero J; León-Juárez EA; Valenzuela-Lara M; Magis-Rodríguez C; Uribe-Zuñiga P; Reyes-Terán G;
    Lancet HIV; 2016 Dec; 3(12):e579-e591. PubMed ID: 27658867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors.
    Bunupuradah T; Suntarattiwong P; Li A; Sirivichayakul S; Pancharoen C; Boonrak P; Puthanakit T; Kerr SJ; Ruxrungtham K; Chotpitayasunondh T; Hirschel B; Ananworanich J;
    Int J Infect Dis; 2010 Apr; 14(4):e311-6. PubMed ID: 19699673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance costs and future drug options of antiretroviral therapies: analysis of the role of NRTIs, NNRTIs, and PIs in a large clinical cohort.
    Maggiolo F; Ripamonti D; Airoldi M; Callegaro A; Arici C; Ravasio V; Bombana E; Goglio A; Suter F
    HIV Clin Trials; 2007; 8(1):9-18. PubMed ID: 17434844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.
    Meriki HD; Tufon KA; Anong DN; Atanga PN; Anyangwe IA; Cho-Ngwa F; Nkuo-Akenji T
    PLoS One; 2019; 14(11):e0225575. PubMed ID: 31751428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.
    Nettles RE; Kieffer TL; Kwon P; Monie D; Han Y; Parsons T; Cofrancesco J; Gallant JE; Quinn TC; Jackson B; Flexner C; Carson K; Ray S; Persaud D; Siliciano RF
    JAMA; 2005 Feb; 293(7):817-29. PubMed ID: 15713771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Provider prescribing of 4 antiretroviral agents after implementation of drug use guidelines in the Department of Veterans Affairs.
    Belperio PS; Mole LX; Boothroyd DB; Backus LI
    J Manag Care Pharm; 2009 May; 15(4):323-34. PubMed ID: 19422272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment Outcomes of Third-line Antiretroviral Regimens in HIV-infected Thai Adolescents.
    Prasitsuebsai W; Sophonphan J; Chokephaibulkit K; Wongsawat J; Kanjanavanit S; Kosalaraksa P; Ngampiyakul C; Sangkla P; Hansudewechakul R; Kerr SJ; Puthanakit T; Ananworanich J;
    Pediatr Infect Dis J; 2017 Oct; 36(10):967-972. PubMed ID: 28520611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The antiretroviral-experienced patient.
    Clark RA; Wilcox R; Besch CL
    Am J Med Sci; 2004 Jul; 328(1):10-6. PubMed ID: 15254437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential drug-drug interactions in HIV-perinatally infected adolescents on antiretroviral therapy in Buenos Aires, Argentina.
    Cordova E; Cecchini D; Rodriguez C
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19764. PubMed ID: 25397508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey.
    Moyo S; Hunt G; Zuma K; Zungu M; Marinda E; Mabaso M; Kana V; Kalimashe M; Ledwaba J; Naidoo I; Takatshana S; Matjokotja T; Dietrich C; Raizes E; Diallo K; Kindra G; Mugore L; Rehle T
    PLoS One; 2020; 15(11):e0241071. PubMed ID: 33147285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Clinical Score to Support Antiretroviral Management of HIV-exposed Infants on the Day of Birth.
    Nesheim SR; Rose C; Pan Y; Mahle Gray K; Rao S; Singh S; Lampe M
    Pediatr Infect Dis J; 2019 Sep; 38(9):939-943. PubMed ID: 31107423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006.
    Buchacz K; Baker RK; Young B; Brooks JT;
    J Acquir Immune Defic Syndr; 2010 Apr; 53(5):625-32. PubMed ID: 19841587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
    Humphreys EH; Chang LW; Harris J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006517. PubMed ID: 20556768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost considerations in the current antiretroviral era.
    Eaton EF; Tamhane A; Saag M; Mugavero MJ; Kilgore ML
    AIDS; 2016 Sep; 30(14):2115-9. PubMed ID: 27088319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
    Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
    Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.